Rasmussen encephalitis and non-herpetic acute limbic encephalitis

Clinical Neurology

Volumn 48, Issue 3, 2008, Pages 163-172

  Takahashi, Yukitoshi ^a   Kubota, Yuko ^a   Yamasaki, Etsuko ^a   Matsuda, Kazumi ^a  

^a SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

Acute limbic encephalitis; Autoantibodies; Cytotoxic T cells; Glutamate receptor; Rasmussen's syndrome

Indexed keywords

AUTOANTIBODY; BRAIN ANTIGEN; DOUBLE STRANDED DNA ANTIBODY; GLUTAMATE RECEPTOR 3; GRANZYME B; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ACUTE DISEASE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHAVIOR DISORDER; CELL HETEROGENEITY; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CHRONIC DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; CONVALESCENCE; CROSS REACTION; DISEASE DURATION; EPILEPSY; EXCITATORY POSTSYNAPTIC POTENTIAL; HUMAN; INCIDENCE; LYMPHOCYTE TRANSFORMATION TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PATCH CLAMP; PERIPHERAL LYMPHOCYTE; RASMUSSEN SYNDROME; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 41649110015     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.48.163     Document Type: Review

References (39)

1. Takahashi Y: Infections as causative factors of epilepsy. Future Neurology 2006; 1: 291-302
2. Japanese source
3. Japanese source
4. Rasmussen T, Olszewski J, Lloyd-Smith D: Focal seizures due to chrome encephalitis. Neurology 1958; 8: 435-445
5. Oguni H, Anderman F, Rasmussen TB: The natural history of the MNI series of forty eight cases. In Chronic Encephalitis and Epilepsy: Rasmussen's Syndrome, ed by Anderman F, Butterworth-Heinemann, Boston, 1991, pp 7-35
6. Bien CG, Granata T, Antozzi C, et al: Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement. Brain 2005; 128: 454-471
7. Rogers SW, Andrews PI, Gahring LC, et al: Autoantibodies to Glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994; 265: 648-651
8. Takahashi Y, Mori H, Mishina M, et al: Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology 2003; 61: 891-896
9. Watson R, Lang B, Bermudez I, et al: Autoantibodies in Rasmussen's encephalitis. J Neuroimmunology 2001; 118: 148
10. Yang R, Puranam RS, Butler LS, et al: Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 2000; 28: 375-383
11. Roubertie A, Boukhaddaoui H, Sieso V, et al: Antiglial Cell Autoantibodies and Childhood Epilepsy: A Case Report Epilepsia 2005; 46: 1308-1312
12. Twyman RE, Gahring LC, Spiess J, et al: Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995; 14: 755-762
13. He XP, Patel M, Whitney KD, et al: Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron 1998; 20: 153-163
14. Levite M, Hermelin A: Autoimmunity to the glutamate receptor in mice - A model for Rasmussen's encephalitis? J of Autoimmunity 1999; 13: 73-82
15. Wiendl H, Bien CG, Bernasconi P, et al: GluR3B antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001; 57: 1511-1514
16. Watson R, Jiang Y, Bermudez I, et al: Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 2004; 63: 43-50
17. Clinical Neuroscience 2006 ; 24 : 219-221
18. DeGiorgio LA, Konstantinov KN, Lee SC, et al: A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-1193
19. Kowal C, Degiorgio LA, Lee JY, et al: Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103: 19854-19859
20. Huerta PT, Kowal C, DeGiorgio LA, et al: Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006; 103: 678-683
21. Takahashi Y, Mori H, Mishina M, et al: Autoantibodies and Cell-mediated Autoimmunity to NMDA-type GluRε2 in Patients with Rasmussen's Encephalitis -and Chronic Progressive Epilepsia Partialis Continua. Epilepsia 2005; 46 (Suppl.5): 152-158
22. Takahashi Y, Matsuda K, Kubota Y, et al: Vaccination and infection as causative factors in Japanese patients with Rasmussen syndrome: Molecular mimicry and HLA class I. Clinical & Developmental Immunology 2006; 13: 381-387
23. Bien CG, Bauer J, Deckwerth TL, et al: Destruction of neurons by cytotoxic T cells: A new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002; 51: 311-318
24. Bien CG, Gleissner U, Sassen R, et al: An open study of tacrolimus therapy in Rasmussen encephalitis. Neurology 2004; 62: 2106-2109
25. Japanese source
26. Japanese source
27. Neuroinfection 2007 ; 12 : 39-44
28. Japanese source
29. Japanese source
30. Neuroinfection in press
31. Vincent A, Buckley C, Schott JM, et al: Potassium channel antibody-associated encephalopathy: a potentially immunotherapyresponsive form of limbic encephalitis. Brain 2004; 127: 701-712
32. Japanese source
33. Fujii A, Yoneda M, Ito T, et al: Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy. J Neuroimmunology 2005; 162: 130-136
34. Japanese source
35. Gultekin SH, Rosenfeld MR, Voltz R, et al: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123: 1481-1494
36. Japanese source
37. Groc L, Heine M, Cousins SL, et al: NMDA receptor surface mobility depends on NR2A-2B subunits. Proc Natl Acad Sci U S A 2006; 103: 18769-18774
38. Dalmau J, Tüzün E, Wu H, et al: Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Associated with Ovarian teratoma. Ann Neurol 2007; 61: 25-36
39. Iizuka T, Sakai F, Ide T, et al: Anti-NMDA receptor encephalitis in Japan. Long-term outcome without tumor removal. Neurology 2007 Sep 26; [Epub ahead of print]